Données récentes sur la production d’anticorps monoclonaux à visée diagnostique en histopathologie

Köhler, 1975, Continuous cultures of fused cells secreting antibody of predefined specificity, Nature, 256, 495, 10.1038/256495a0 McCafferty, 1990, Phage antibodies: filamentous phage displaying antibody variable domains, Nature, 348, 552, 10.1038/348552a0 Harlow, 1988 Al Saati, 1987, Production of monoclonal antibodies using spleen cells from nude mice bearing human tumors, Ann Pathol, 7, 1 Al Saati, 1989, Production of anti-B monoclonal antibodies (DBB.42, DBA.44, DNA.7, and DND.53) reactive on paraffin-embedded tissues with a new B-lymphoma cell line grafted into athymic nude mice, Blood, 74, 2476, 10.1182/blood.V74.7.2476.2476 Spieker-Polet, 1995, Rabbit monoclonal antibodies: generating a fusion partner to produce rabbit-rabbit hybridomas, Proc Natl Acad Sci USA, 92, 9348, 10.1073/pnas.92.20.9348 Rossi, 2005, Rabbit monoclonal antibodies: a comparative study between a novel category of immunoreagents and the corresponding mouse monoclonal antibodies, Am J Clin Pathol, 124, 295, 10.1309/NR8HN08GDPVEMU08 Huang, 2005, Development of new rabbit monoclonal antibody to estrogen receptor: immunohistochemical assessment on formalin-fixed, paraffin-embedded tissue sections, Appl Immunohistochem Mol Morphol, 13, 91, 10.1097/00129039-200503000-00015 Cheuk, 2004, Consistent immunostaining for cyclin D1 can be achieved on a routine basis using a newly available rabbit monoclonal antibody, Am J Surg Pathol, 28, 801, 10.1097/01.pas.0000126054.95798.94 Watkins, 2000, Introduction to antibody engineering and phage display, Vox Sang, 78, 72, 10.1046/j.1423-0410.2000.7820072.x Nissim, 2008, Historical development of monoclonal antibody therapeutics, Handb Exp Pharmacol, 181, 3, 10.1007/978-3-540-73259-4_1 Winter, 1994, Making antibodies by phage display technology, Annu Rev Immunol, 12, 433, 10.1146/annurev.iy.12.040194.002245 Jakobovits, 2007, From XenoMouse technology to panitumumab, the first fully human antibody product from transgenic mice, Nat Biotechnol, 25, 1134, 10.1038/nbt1337 Kenanova, 2006, Tailoring antibodies for radionuclide delivery, Expert Opin Drug Deliv, 3, 53, 10.1517/17425247.3.1.53 van Dongen, 2007, Immuno-PET: a navigator in monoclonal antibody development and applications, Oncologist, 12, 1379, 10.1634/theoncologist.12-12-1379 Zinzani, 2008, Consensus conference: implementing treatment recommendations on yttrium-90 immunotherapy in clinical practice - report of a European workshop, Eur J Cancer, 44, 366, 10.1016/j.ejca.2007.12.008 Wark, 2006, Latest technologies for the enhancement of antibody affinity, Adv Drug Deliv Rev, 58, 657, 10.1016/j.addr.2006.01.025 De Genst, 2006, Antibody repertoire development in camelids, Dev Comp Immunol, 30, 187, 10.1016/j.dci.2005.06.010 Muyldermans, 2009, Camelid immunoglobulins and nanobody technology, Vet Immunol Immunopathol, 128, 178, 10.1016/j.vetimm.2008.10.299